Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Gary Mohilner who wrote (3723)	11/23/2000 3:00:53 PM
From: Sonny	Read Replies (2) \| Respond to of 5665

Happy Thanksgiving Gary and all! Gary, you are very correct ... a year from now, if we have the pancreatic-cancer-cure in the bag, these 30s, 40s prices will look like peanuts. Then we are looking at IMGN prices rising forever and not looking back ... perhaps 1600 (i.e. 100 after 4 splits) is not a far fetched dream in the intermediate to long term time-frame, if the scenario really takes the shape, as if the IMGN technology framework becomes the foundation on which to launch the research projects for curing all other kinds of cancers. I know, its hard for most people to fathom these prices right now, but we, the very-long-time-IMGN-longs, know it very well - the $1 price ranges of IMGN papers, and most would just ignore us or consider you a lunatic, if you had told them that one day, in less than 2-3 years, it will trade in the 40 dollar range. But again, even this level now is also a tremendous bargain if the above scenario truly materializes in its full colors. This year, the glory year of IMGN in the last 7, you especially deserve a very heart-warming thanks from all of us IMGNites here, for your consistent and tireless efforts to keep everybody well informed. regards to all, -/Sonny.